Seeing Is Believing
Currently out of the existing stock ratings of Mark Purcell, 25 are a HOLD (43.86%), 11 are a SELL (19.3%), 21 are a BUY (36.84%).
Analyst Mark Purcell, currently employed at MORGAN STANLEY, carries an average stock price target met ratio of 45.15% that have a potential upside of 17.62% achieved within 307 days.
Mark Purcell’s has documented 112 price targets and ratings displayed on 6 stocks. The coverage is on the Healthcare sector.
Most recent stock forecast was given on SNY, Sanofi ADR at 08-Sep-2025.
Analyst best performing recommendations are on NVO (NOVO NORDISK A/S).
The best stock recommendation documented was for NVO (NOVO NORDISK A/S) at 8/11/2021. The price target of $49.49 was fulfilled within 9 days with a profit of $2.59 (5.52%) receiving and performance score of 6.14.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Time (Days) For PT To Be Met
Performance score
Buy
$87
$1.69 (1.98%)
$78
10 months 18 days ago
(17-Nov-2024)
8/9 (88.89%)
$24.91 (40.12%)
639
Buy
$88
$2.69 (3.15%)
$82
10 months 23 days ago
(12-Nov-2024)
4/5 (80%)
$24.05 (37.61%)
315
Buy
$95
$9.69 (11.36%)
$66
1 years 1 months 24 days ago
(11-Aug-2024)
6/7 (85.71%)
$14.17 (17.53%)
501
Buy
$85
$-0.31 (-0.36%)
$80
1 years 4 months 6 days ago
(29-May-2024)
4/4 (100%)
$10.26 (13.73%)
414
Buy
$84
$-1.31 (-1.54%)
$85
1 years 5 months 14 days ago
(21-Apr-2024)
2/12 (16.67%)
$15.73 (23.04%)
170
Which stock is Mark Purcell is most bullish on?
What Year was the first public recommendation made by Mark Purcell?